(WELL) WELL Health Technologies - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA94947L1022
WELL: Electronic, Medical, Records, Telehealth, Software, Billing, Cybersecurity
WELL Health Technologies Corp. is a practitioner-focused digital healthcare company operating in Canada, the United States, and internationally. It delivers omni-channel patient services and solutions across specialized markets, including medical recruitment, anesthesia, gastrointestinal health, and primary care. The company also develops and integrates its own suite of technology solutions for healthcare providers, including Electronic Medical Records (EMR) systems like OSCAR, Juno, Profile (Intrahealth), and Cerebrum (AwareMD). Its platform offers telehealth services, practice management tools, AI-powered virtual assistants (WELL AI Voice), billing and revenue cycle management solutions, and cybersecurity protections for patient data. WELL Health has expanded its capabilities through strategic acquisitions, building a comprehensive ecosystem that supports healthcare practitioners and clinics. Founded in 2010 and headquartered in Vancouver, Canada, the company has established itself as a key player in the digital transformation of healthcare services.
From a technical perspective, WELL Healths stock (TO:WELL) is currently trading at $3.95, below its 20-day SMA of $4.01, suggesting short-term downward momentum. The stocks 50-day and 200-day SMAs of $4.75 and $4.90, respectively, indicate a broader downtrend. The average trading volume over 20 days is 844,800 shares, with an ATR of $0.24, reflecting moderate volatility. On the fundamental side, the companys market cap stands at $948.40M CAD, with a P/E ratio of 28.85 and a forward P/E of 10.00, signaling expectations of future earnings growth. The P/B ratio of 1.09 and P/S ratio of 1.03 suggest the stock is reasonably valued relative to its book value and sales. However, the RoE of 3.76% indicates room for improvement in profitability. Overall, while the stock may face near-term headwinds, its valuation metrics and growth prospects could attract long-term investors seeking exposure to the digital healthcare sector.
Additional Sources for WELL Stock
WELL Stock Overview
Market Cap in USD | 724m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception |
WELL Stock Ratings
Growth Rating | 86.4 |
Fundamental | 47.9 |
Dividend Rating | 0.0 |
Rel. Strength | 62.6 |
Analysts | - |
Fair Price Momentum | 5.09 CAD |
Fair Price DCF | - |
WELL Dividends
No Dividends PaidWELL Growth Ratios
Growth Correlation 3m | -96% |
Growth Correlation 12m | 73.3% |
Growth Correlation 5y | 87.7% |
CAGR 5y | 79.58% |
CAGR/Max DD 5y | 1.63 |
Sharpe Ratio 12m | -0.08 |
Alpha | 35.46 |
Beta | 2.115 |
Volatility | 48.93% |
Current Volume | 939.7k |
Average Volume 20d | 772.9k |
As of May 09, 2025, the stock is trading at CAD 3.89 with a total of 939,685 shares traded.
Over the past week, the price has changed by -1.77%, over one month by -2.75%, over three months by -36.33% and over the past year by +56.01%.
Partly, yes. Based on ValueRay Fundamental Analyses, WELL Health Technologies (TO:WELL) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.87 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WELL as of May 2025 is 5.09. This means that WELL is currently undervalued and has a potential upside of +30.85% (Margin of Safety).
WELL Health Technologies has no consensus analysts rating.
According to ValueRays Forecast Model, WELL WELL Health Technologies will be worth about 6 in May 2026. The stock is currently trading at 3.89. This means that the stock has a potential upside of +53.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7.9 | 102.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 6 | 53.5% |